# 119-hr-9186: Controlled Substances Act Clarification in Sciences Act of 2026

119-hr-9186, Controlled Substances Act Clarification in Sciences Act of 2026, is a 119th Congress bill sponsored by Rep. Cohen, Steve [D-TN-9] (D-TN); status introduced; PRIA reads it as touching household money (as of 2026-06-27).

- Canonical: https://policyrisk.com/legislation/119-hr-9186
- As of: 2026-06-27
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-9186
- Congress: 119
- Title: Controlled Substances Act Clarification in Sciences Act of 2026
- Status: introduced
- Introduced: 2026-06-08
- Sponsor: Rep. Cohen, Steve [D-TN-9] (D-TN)
- Cosponsors: 0
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-06-27

## Summary

**Science-based scheduling** refocuses drug classification so decisions follow modern medical and scientific evaluations and explicitly weigh public health, medical access, and societal benefits. It also updates core terms like accepted medical use, dependence, abuse, misuse, and lack of accepted safety to reflect contemporary medical practice. - Patients and health care practitioners: Clarifies when a drug counts as an accepted medical use by tying it to FDA approval, Public Health Service licensure, or recognized medical practice in other jurisdictions, which helps define legal medical access. - Researchers and the scientific community: Treats legitimate scientific research as an accepted medical use and elevates the Secretary's scientific and medical evaluation as the primary basis for scheduling decisions. - Law enforcement and regulators: Directs the Attorney General to align scheduling choices with the Secretary's medical findings and to choose schedules that match controls to health risks while preserving access and recognizing societal benefits.

## Provisions PRIA read

- Drug scheduling guided by science: mixed, medium. If enacted, this would change how the government decides drug schedules. The Attorney General would need to defer to the Secretary’s scientific and medical evaluation when placing or moving drugs in schedules. Agencies would have to choose schedules that protect public health and safety while prese…

## Related bills

- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-7977: Energy Bills Relief Act
- 119-hr-7481: Department of Homeland Security Appropriations Act, 2026
- 119-hr-7973: Momnibus Act
- 119-hr-4714: End Polluter Welfare Act of 2025
- 119-hr-3971: Domestic Workers Bill of Rights Act

## Sources
- [119-hr-9186 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/9186)

## Related
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-7977: Energy Bills Relief Act](https://policyrisk.com/legislation/119-hr-7977)
- [119-hr-7481: Department of Homeland Security Appropriations Act, 2026](https://policyrisk.com/legislation/119-hr-7481)
- [119-hr-7973: Momnibus Act](https://policyrisk.com/legislation/119-hr-7973)
- [119-hr-4714: End Polluter Welfare Act of 2025](https://policyrisk.com/legislation/119-hr-4714)
- [119-hr-3971: Domestic Workers Bill of Rights Act](https://policyrisk.com/legislation/119-hr-3971)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-9186 (as of 2026-06-27).